BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5314460)

  • 1. [Importance of factor II determination during treatments with vitamin K inhibitors].
    Plouvier SR; Arnold M
    Agressologie; 1971; 12(1):41-8. PubMed ID: 5314460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intramural hematoma of the digestive tract from vitamin K antagonists].
    Costecalde M; Pradère B; Parent Y; Barret A; Gouzi JL; Gédéon A
    Ann Chir; 1984 Feb; 38(1):31-6. PubMed ID: 6608911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intramural hematoma of the intestine caused by anticoagulants (3 cases, 1 of them of the colon)].
    Huguier M; Vinh TS; Cerbonnet G
    Chirurgie; 1972 May; 98(7):427-32. PubMed ID: 4538778
    [No Abstract]   [Full Text] [Related]  

  • 4. [The adult intensive care physician and antivitamin K agents].
    Auzépy P; Rimailho A; Souied G; Riou B
    Agressologie; 1983 Nov; 24(11):549-54. PubMed ID: 6367510
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral anticoagulants.
    Winter JH; Douglas AS
    Clin Haematol; 1981 Jun; 10(2):459-80. PubMed ID: 7032784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal reversal of vitamin K antagonists.
    Schulman S
    Thromb Res; 2007; 119(1):15-6. PubMed ID: 16310838
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the control of anticoagulant therapy.
    Owren PA
    Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical implications of new oral anticoagulants: will the potential advantages be achieved?
    Phillips KW; Ansell J
    Thromb Haemost; 2010 Jan; 103(1):34-9. PubMed ID: 20062925
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of a new antivitamin K: 6134 M.D. 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol].
    Pernod J; Kermarec J; Migne J
    Therapie; 1968; 23(3):567-74. PubMed ID: 4906093
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vitamin K antagonists: mechanism of anticoagulant action and laboratory control over therapy (a lecture)].
    Lipatova NA; Titaeva EV; Dobrovol'skiĭ AB
    Klin Lab Diagn; 2006 May; (5):25-32. PubMed ID: 16827235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of standardization in the biological monitoring of anti-vitamin K therapy].
    Forestier F; Boneu B; Potron G; Boisseau M; Coqueret B; Saffar S; Chambrette B
    Nouv Rev Fr Hematol (1978); 1986; 28(3):157-62. PubMed ID: 3748800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methods of controlling therapy with secondary-action anticoagulants].
    Kotovshchikova MA; Khanina TM
    Vrach Delo; 1973 May; 5():8-12. PubMed ID: 4593417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electronarcosis while under anticoagulant treatment].
    Loo H; Cuche H; Dusorbier X; Attali M
    Ann Med Psychol (Paris); 1980 Feb; 138(2):234-40. PubMed ID: 7387052
    [No Abstract]   [Full Text] [Related]  

  • 18. The third hemostatic vitamin.
    Quick AJ
    Wis Med J; 1972 Jul; 71(7):175-81. PubMed ID: 4114336
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin K antagonists].
    D'Agostino F; D'Agostino M; Cambiè G; Cuccia A
    Riv Emoter Immunoematol; 1983; 30(1):1-31. PubMed ID: 6635478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of "prothrombin-coagulase" activity].
    Soulier JP; Prou-Wartelle O
    Nouv Rev Fr Hematol; 1970; 10(1):41-54. PubMed ID: 4246336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.